Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
34.26
EUR
-1.75%
Market Closed
Market Cap:
€2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
T
|
Thai Beverage PCL
XMUN:T6W
|
TH |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
|
System1 Group PLC
LSE:SYS1
|
UK |
|
I
|
ITV PLC
F:IJ7
|
UK |
|
C
|
China Coal Energy Co Ltd
XMUN:CVV
|
CN |
|
B
|
Boeing Co
SGO:BA
|
US |
|
M
|
McCormick & Company Inc
XMUN:MCX
|
US |
|
J
|
J B Hunt Transport Services Inc
XMUN:JB1
|
US |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
N
|
Nov Inc
SWB:NO8
|
US |
|
B
|
Ba Airport Leasehold Real Estate Investment Trust
SET:BAREIT
|
TH |
|
Daiwa House Industry Co Ltd
F:DWH
|
JP |
|
G
|
Getlink SE
XMUN:TNU3
|
FR |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
N
|
NTT Data Corp
F:NT5
|
JP |
|
A
|
Aegon NV
XHAM:AEND
|
NL |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
DE |
|
C
|
Cooper Companies Inc
BMV:COO
|
US |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
Sabra Health Care REIT Inc
F:SBC
|
US |
Wall St Price Targets
TCE2 Price Targets Summary
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Wall Street analysts forecast TCE2 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TCE2 is 32.25 EUR with a low forecast of 21.16 EUR and a high forecast of 57.88 EUR.
Lowest Forecast
Price Target
21.16
EUR
38% Downside
Average Forecast
Price Target
32.25
EUR
6% Downside
Highest Forecast
Price Target
57.88
EUR
69% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TCE2's stock price target?
Price Target
32.25
EUR
32.25
EUR
According to Wall Street analysts, the average 1-year price target for TCE2 is 32.25 EUR with a low forecast of 21.16 EUR and a high forecast of 57.88 EUR.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.
